Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone

por Alkharabsheh, Omar, Bellman, Polina, Mahmoudjafari, Zahra, Cui, Wei, Atrash, Shebli, Paul, Barry, Hashmi, Hamza, Shune, Leyla, Ahmed, Nausheen, Abdallah, Al-Ola
Publicado 2023